Healthcare provider profile · identity verified

Necholas Ghannam, MD

Internal Medicine · CHICAGO, IL · NPI 1962480541

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	1049	286
Atorvastatin Calcium	Atorvastatin Calcium	972	285
Losartan Potassium	Losartan Potassium	461	127
Gabapentin	Gabapentin	371	112
Hydrochlorothiazide	Hydrochlorothiazide	349	109
Metoprolol Succinate	Metoprolol Succinate	346	102
Metformin Hcl	Metformin Hcl	345	89
Lisinopril	Lisinopril	341	92
Rosuvastatin Calcium	Rosuvastatin Calcium	276	82
Furosemide	Furosemide	275	91
Omeprazole	Omeprazole	244	68
Albuterol Sulfate Hfa	Albuterol Sulfate	214	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	210	52
Carvedilol	Carvedilol	204	54
Spironolactone	Spironolactone	188	53
Fluticasone Propionate	Fluticasone Propionate	186	68
Levothyroxine Sodium	Levothyroxine Sodium	169	47
Tamsulosin Hcl	Tamsulosin Hcl	169	57
Allopurinol	Allopurinol	168	47
Metformin Hcl Er	Metformin Hcl	166	54
Triamcinolone Acetonide	Triamcinolone Acetonide	150	57
Donepezil Hcl	Donepezil Hcl	147	46
Metoprolol Tartrate	Metoprolol Tartrate	147	48
Ozempic	Semaglutide	142	30
Famotidine	Famotidine	127	33
Pantoprazole Sodium	Pantoprazole Sodium	127	47
Hydralazine Hcl	Hydralazine Hcl	126	41
Eliquis	Apixaban	125	28
Trazodone Hcl	Trazodone Hcl	125	25
Pravastatin Sodium	Pravastatin Sodium	124	36
Jardiance	Empagliflozin	114	26
Potassium Chloride	Potassium Chloride	113	38
Simvastatin	Simvastatin	110	33
Nifedipine Er	Nifedipine	108	33
Irbesartan	Irbesartan	104	26
Clopidogrel	Clopidogrel Bisulfate	100	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	95	27
Alprazolam	Alprazolam	94	25
Memantine Hcl	Memantine Hcl	88	26
Baclofen	Baclofen	86	27
Lovastatin	Lovastatin	86	23
Diclofenac Sodium	Diclofenac Sodium	82	23
Tramadol Hcl	Tramadol Hcl	82	27
Acetaminophen-Codeine	Acetaminophen With Codeine	81	19
Duloxetine Hcl	Duloxetine Hcl	81	18
Montelukast Sodium	Montelukast Sodium	80	15
Alendronate Sodium	Alendronate Sodium	79	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	25
Sertraline Hcl	Sertraline Hcl	73	27
Glipizide Er	Glipizide	70	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	70	21
Trulicity	Dulaglutide	67	11
Glipizide	Glipizide	66	15
Ibuprofen	Ibuprofen	63	21
Warfarin Sodium	Warfarin Sodium	61	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	18
Arnuity Ellipta	Fluticasone Furoate	57	suppressed
Glimepiride	Glimepiride	56	17
Oxybutynin Chloride Er	Oxybutynin Chloride	56	11
Mirtazapine	Mirtazapine	55	15
Enalapril Maleate	Enalapril Maleate	52	16
Symbicort	Budesonide/Formoterol Fumarate	52	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Sildenafil Citrate	Sildenafil Citrate	51	12
Oxybutynin Chloride	Oxybutynin Chloride	49	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	15
Benazepril Hcl	Benazepril Hcl	44	14
Escitalopram Oxalate	Escitalopram Oxalate	44	11
Felodipine Er	Felodipine	43	12
Ventolin Hfa	Albuterol Sulfate	43	11
Dropsafe Prep Pads	Alcohol Antiseptic Pads	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Meclizine Hcl	Meclizine Hcl	39	16
Vitamin D2	Ergocalciferol (Vitamin D2)	38	suppressed
Ramipril	Ramipril	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Amoxicillin	Amoxicillin	36	31
Farxiga	Dapagliflozin Propanediol	36	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Levetiracetam	Levetiracetam	35	suppressed
Meloxicam	Meloxicam	35	12
Clonidine Hcl	Clonidine Hcl	33	suppressed
Entresto	Sacubitril/Valsartan	33	suppressed
Finasteride	Finasteride	33	12
Labetalol Hcl	Labetalol Hcl	32	suppressed
Prednisone	Prednisone	31	16
Januvia	Sitagliptin Phosphate	30	suppressed
Topiramate	Topiramate	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Naproxen	Naproxen	27	suppressed
Colchicine	Colchicine	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Pregabalin	Pregabalin	23	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Valsartan	Valsartan	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Nystatin	Nystatin	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Linzess	Linaclotide	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lorazepam	Lorazepam	16	suppressed
Nateglinide	Nateglinide	16	suppressed
Primidone	Primidone	16	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Clonidine	Clonidine	15	suppressed
Dulera	Mometasone/Formoterol	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Econazole Nitrate	Econazole Nitrate	14	suppressed
Ibu	Ibuprofen	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Risperidone	Risperidone	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Lidocaine	Lidocaine	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Torsemide	Torsemide	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Hydrocortisone	Hydrocortisone	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error